Target intelligence / Profile preview

Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6)

Target
UQCC6
Molecular classification
Other (Mitochondrial small protein/microprotein), Assembly factor (mitochondrial respiratory chain)
01

Overview

Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6, also known as BRAWNIN) is a highly conserved, nuclear-encoded mitochondrial microprotein required for the assembly and stability of the mitochondrial respiratory chain complex III (cytochrome b-c1 complex), essential for electron transport and oxidative phosphorylation. UQCC6/BRAWNIN is localized to the inner mitochondrial membrane, where it functions as an early assembly factor of complex III, regulating mitochondrial ATP production in response to cellular energy status. Depletion or mutation of UQCC6 results in impaired complex III formation, reduced ATP production, metabolic dysfunction (including lactic acidosis), growth retardation, and early lethality in model organisms. UQCC6 expression is tightly regulated by the energy-sensing AMPK-PGC1α pathway, linking it to bioenergetic adaptation and potentially broader metabolic and immune functions[1][2][3][8].

Other names
BRAWNINBRProtein BRAWNINC12orf73FLJ13975DKFZp547P055uncharacterized protein C12orf73
02

Mechanism of action

Not applicable (no current drugs); future targeting would likely involve modulation of complex III assembly or mitochondrial function

03

Biological functions

Mitochondrial respiratory chain complex III assemblyRegulation of electron transport chain/oxidative phosphorylationRegulation of cellular energy homeostasis
04

Disease associations

Mitochondrial disease (complex III deficiency, growth retardation, lactic acidosis)Potential role in metabolism-related disordersPossible implication in immune function via mitochondrial respiratory chain integrity
05

Safety considerations

Potential safety concerns in targeting include disruption of mitochondrial function, impaired oxidative phosphorylation, lactic acidosis, growth retardation, and organ dysfunction
06

Biomarkers

Loss-of-function mutations in UQCC6/C12orf73 as a biomarker for certain mitochondrial diseases (complex III assembly disorders)

Beyond the preview

Go deeper on Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquinol-cytochrome c reductase complex assembly factor 6 (UQCC6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call